IQVIA Holdings Inc. (NYSE: IQV) Stock Analysis & Fundamentals | ScreenerHero

Create free account

IQVIQVIA Holdings Inc.

NYSE · US · Healthcare · Diagnostics & Research · iqvia.com

207.85USD-0.54%Mkt Cap: 34.69B $P/E: 25.82Today

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates …

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$195.86BUSDP/E 28.9

Danaher Corporation

$140.88BUSDP/E 38.7

$46.71BUSDP/E 45.1

IDEXX Laboratories, Inc.

$44.46BUSDP/E 41.5

Agilent Technologies, Inc.

$37.93BUSDP/E 27.0

Waters Corporation

$36.96BUSDP/E 48.0

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.19BUSDP/E 30.4

Quest Diagnostics Incorporated

$22.96BUSDP/E 22.9

Labcorp Holdings Inc.

$22.70BUSDP/E 24.5

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.37BUSDP/E 33.9

Eurofins Scientific SE

$12.97BUSDP/E 27.0

$12.53BUSDP/E 54.0

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.01BUSDP/E 21.0

BillionToOne, Inc.

$5.83BUSDP/E 234.8

Twist Bioscience Corporation

Sotera Health Company

$5.25BUSDP/E 44.9

$4.55BUSDP/E 52.8

DiaSorin S.p.A.

$3.70BUSDP/E 26.1

Adaptive Biotechnologies Corporation

GeneDx Holdings Corp.

NeoGenomics, Inc.

Vimian Group AB (publ)

$1.54BUSDP/E 39.0

Diagnostyka S.A.

$1.55BUSDP/E 23.5

Personalis, Inc.

Clínica Baviera, S.A.

$1.01BUSDP/E 21.1

OPKO Health, Inc.

Castle Biosciences, Inc.

$655.97MUSDP/E 42.7

Fulgent Genetics, Inc.

Myriad Genetics, Inc.

$297.91MUSDP/E 3.0

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

ENDRA Life Sciences Inc.

Proteome Sciences plc

Avricore Health Inc.

Oxford BioDynamics Plc

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

$3.86MUSDP/E 2.8

Telo Genomics Corp.

Prostatype Genomics AB (publ)

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap34.69B $

Enterprise Value49.12B $

Revenue (TTM)16.63B $

Gross Profit5.43B $

Net Income (TTM)1.36B $

Revenue/Share97.79 USD

Last Price207.85 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees93.0K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS46266C1053

Valuation

P/E (Trailing)25.82

P/E (Forward)14.73

PEG0.82

EV/EBITDA16.37

EV/Revenue2.95

P/S2.10

P/B5.61

EPS (TTM)8.25

EPS (Forward)14.19

52W Range

154.5058% of range247.05

52W High247.05 USD

52W Low154.50 USD

Profitability

Gross Margin33.29%

Oper. Margin13.61%

EBITDA Margin18.04%

Profit Margin8.34%

ROE20.91%

ROA4.54%

Growth

Revenue Growth8.40%

Earnings Growth15.00%

Cash Flow & Leverage

Operating CF2.65B $

CapEx (TTM)603.00M $

FCF Margin12.97%

FCF Yield6.22%

Net Debt14.11B $

Net Debt/EBITDA4.70

Balance Sheet

Debt/Equity2.45

Current Ratio0.75

Quick Ratio0.66

Book Value/Sh37.27 USD

Cash/Share12.60 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.5 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)229.63 USD

Upside (mean)+10.5%

Target Range200.00 USD – 284.00 USD

$200.00+10.5% to mean$284.00

# Analysts19

Ownership

Shares Out.166.90M

Float158.55M

Insiders1.08%

Institutions104.05%

Short Interest

Short Ratio3.0d

Short % Float3.49%

Short % Out.3.01%

Shares Short5.03M

Short (prev mo.)4.93M

Technical

SMA 50178.39 (+16.5%)

SMA 200195.68 (+6.2%)

Beta1.20

S&P 52W Chg20.11%

Avg Vol (30d)1.15M

Avg Vol (10d)1.49M

Technical Indicators

RSI (14)68.3

MACD8.4212

MACD Signal6.4382

MACD Hist.+1.9830

BB Upper218.95 USD

BB Middle189.61 USD

BB Lower160.28 USD

BB Width30.94%

ATR (14)6.825 USD

Vol Ratio (20d)0.42x